Related Experiment Video
Updated: Aug 3, 2026

12:16
A Syngeneic Mouse B-Cell Lymphoma Model for Pre-Clinical Evaluation of CD19 CAR T Cells
Published on: October 16, 2018
An animal model for intractable chronic lymphocytic leukemia
1Research Service, Veterans Administration Hospital, Hines IL.
Medical Hypotheses
|November 1, 1990
Summary
X-irradiation induced lymphomas in mice, revealing two distinct radiosensitivity groups. Some lymphomas mimicked human chronic lymphocytic leukemia (CLL), offering models for studying intractable disease treatments.
Area of Science:
- Oncology
- Radiation Biology
- Immunology
Background:
- X-irradiation can induce lymphomas in experimental models.
- Cellular radiosensitivity varies significantly within lymphoma populations.
- Understanding lymphoma radiosensitivity is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the radiosensitivity of X-irradiation-induced lymphomas in mice.
- To characterize distinct radiosensitivity profiles within these lymphomas.
- To establish animal models for studying human chronic lymphocytic leukemia (CLL).
Main Methods:
- Induction of lymphomas in mice using X-irradiation.
- Assessment of lymphoma cell radiosensitivity.
- Comparative analysis of lymphoma cell radiosensitivity to normal murine lymphocytes.
- Categorization of lymphomas into radiosensitive and radioresistant groups.
Main Results:
- Lymphomas developed following X-irradiation treatment in mice.
- Lymphoma cell radiosensitivity exhibited a bimodal frequency distribution.
- 11 lymphomas showed radiosensitivity similar to normal murine lymphocytes.
- 6 lymphomas demonstrated high radioresistance.
- Radiosensitive and radioresistant lymphomas were found to be analogous to responsive and intractable chronic lymphocytic leukemia (CLL) in humans, respectively.
Conclusions:
- X-irradiation-induced murine lymphomas present distinct radiosensitivity profiles.
- These lymphomas serve as valuable models for human chronic lymphocytic leukemia (CLL).
- The radioresistant lymphoma model is suitable for in vitro and in vivo studies of therapeutic agents for intractable CLL.

